Medicines
- Estradiol tablets estradiol · Generic available Advanced breast cancer (to ease symptoms)
- Xeloda capecitabine · Generic available Advanced breast cancer
- Evista raloxifene · Generic available Lowering the risk of invasive breast cancer after menopause
- Arimidex anastrozole · Generic available Breast cancer after menopause
- Tamoxifen Generic available
- Afinitor everolimus · Generic available HR-positive, HER2-negative breast cancer after menopause
- Aromasin exemestane · Generic available Breast cancer after menopause
- Femara letrozole · Generic available Breast cancer after menopause
- Faslodex fulvestrant · Generic available Hormone receptor-positive advanced breast cancer
- Halaven eribulin · Generic available Breast cancer that has spread
- Premarin conjugated estrogens · Generic available Breast cancer that has spread (to ease symptoms)
- Abraxane paclitaxel · Generic available Breast cancer that has spread (metastatic)
- Taxotere docetaxel · Generic available
- Fareston toremifene · Generic available Breast cancer that has spread, after menopause
- Tykerb lapatinib · Generic available HER2-positive breast cancer
- Cligavyx fulvestrant · No generic yet Hormone receptor-positive advanced breast cancer
- Cytoxan cyclophosphamide · Generic available
- Datroway datopotamab deruxtecan · No generic yet Advanced triple-negative breast cancer; Hormone receptor-positive, HER2-negative advanced breast cancer
- Docivyx docetaxel · No generic yet
- Doxorubicin No generic yet
- Enhertu fam-trastuzumab deruxtecan-nxki · No generic yet HER2-positive breast cancer; HER2-low or HER2-ultralow breast cancer
- Etcamah camizestrant · No generic yet HR-positive, HER2-negative breast cancer with ESR1 mutation
- Favlyxa fluorouracil · No generic yet
- Frindovyx cyclophosphamide · No generic yet
- Herceptin trastuzumab · No generic yet HER2-positive breast cancer
- Herceptin Hylecta trastuzumab and hyaluronidase-oysk · No generic yet HER2-positive breast cancer
- Hercessi trastuzumab-strf · No generic yet HER2-positive breast cancer
- Herzuma trastuzumab · No generic yet HER2-positive breast cancer
- Ibrance palbociclib · No generic yet HR-positive, HER2-negative advanced breast cancer; HR-positive, HER2-positive advanced breast cancer
- Inluriyo imlunestrant · No generic yet Advanced breast cancer with an ESR1 mutation
- Itovebi inavolisib · No generic yet HR+, HER2- breast cancer with a PIK3CA mutation
- Kadcyla ado-trastuzumab emtansine · No generic yet HER2-positive breast cancer
- Kanjinti trastuzumab-anns · No generic yet HER2-positive breast cancer
- Keytruda pembrolizumab · No generic yet Triple-negative breast cancer
- Keytruda Qlex pembrolizumab and berahyaluronidase alfa-pmph · No generic yet Triple-negative breast cancer
- Kisqali ribociclib · No generic yet HR-positive, HER2-negative breast cancer
- Lynparza olaparib · No generic yet BRCA-mutated, HER2-negative breast cancer
- Nerlynx neratinib · No generic yet HER2-positive breast cancer
- Ogivri trastuzumab-dkst · No generic yet HER2-positive breast cancer
- Ontruzant trastuzumab · No generic yet HER2-positive breast cancer
- Orserdu elacestrant · No generic yet Advanced breast cancer with an ESR1 mutation
- Perjeta pertuzumab · No generic yet HER2-positive breast cancer
- Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf · No generic yet HER2-positive breast cancer
- Piqray alpelisib · No generic yet Advanced HR+, HER2- breast cancer with a PIK3CA mutation
- Soltamox tamoxifen · No generic yet Estrogen receptor-positive breast cancer; Lowering the risk of invasive breast cancer after DCIS; Lowering the risk of breast cancer in high-risk women
- Talzenna talazoparib · No generic yet HER2-negative breast cancer with a BRCA gene change
- Trazimera trastuzumab-qyyp · No generic yet HER2-positive breast cancer
- Trodelvy sacituzumab govitecan · No generic yet Triple-negative breast cancer; HR-positive, HER2-negative breast cancer
- Truqap capivasertib · No generic yet HR+, HER2- breast cancer with a PIK3CA, AKT1 or PTEN gene change
- Tukysa tucatinib · No generic yet HER2-positive breast cancer
- Veppanu vepdegestrant · No generic yet ER-positive, HER2-negative breast cancer with ESR1 mutation
- Verzenio abemaciclib · No generic yet HR-positive, HER2-negative breast cancer
- Zoladex goserelin · No generic yet Advanced breast cancer before or near menopause
From each medicine’s FDA label. Only your prescriber can say which one is right for you, and many are prescribed for other reasons too.